al • da • tu [ɒl - də - tu]: to become something different

Aldatu Biosciences Navigation
  • Who We Are
  • A Global Problem
    • HIV Drug Resistance
  • Our Solution
  • News
  • Search
  • Who We Are
  • A Global Problem
    • HIV Drug Resistance
  • Our Solution
  • News
  • Search

Aldatu Biosciences Receives $1.5 Million Direct-to-Phase II SBIR Grant from the NIAID for HIV Drug Resistance Diagnostic Development

Cambridge, MA, 12th March 2015 (download press release .pdf) Aldatu Biosciences, a novel diagnostics platform company focused on improving HIV patient care globally, today announced it has been awarded a Direct-to-Phase …

© Aldatu Biosciences 2018

Aldatu HQ

Contact Us

Aldatu Biosciences, 127 Western Ave, Harvard Life Lab, Boston MA 02134

Email: change@aldatubio.com

For career and internship opportunities, please click here.

Toggle the Widgetbar
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the Aldatu Biosciences website. However, if you would like to, you can change your cookie settings at any time.Okay